Longitudinal study on prevalence, incidence and persistence of SARS-CoV-2 antibodies in health care workers using home blood collection kits and a fully automated ELISA and ECLIA antibody assay

Overview

Acronym
LSPIPSA_HCW
Investigators
  • Dr. Keith Jarvi

    Mount Sinai Hospital

Contacts
  • Susan Lau

    Mount Sinai Hospital

General Design

Study design
Cohort
Start Year
2020
End Year
2022
General Information on Follow Up (profile, frequency)
For the longitudinal participants, follow-up questionnaires were completed at 3, 6, 12 and 18 months following the initial assays; and 30 days after the completion of the vaccination. An identical process was followed for the serological testing 3, 6, 12 and 18 months following the initial assays; and 30 days after the completion of vaccination.
Recruitment Target
  • Individuals
Number of Participants
1,720
Number of Participants with Biological Samples
1,720
Supplementary information about number of participants
COVID-19 infected: 10 participants
COVID-19 negative and untested: 10 participants
Mount Sinai Hospital: 1200 Participants
Health Science North (Sudbury): 250 Participants
Sault Area Hospital (Sault Ste Marie): 250 Participants

Access

Availability of data and biosamples

Possible Access to Data
Possible Access to Biosamples
Other

Timeline

Populations

LSPIPSA-HCW - COVID-19 infected

Selection Criteria

Countries
  • Canada
Territory
Toronto
Health Status
  • COVID-19 positive and recovered

Sources of Recruitment

Specific Population
  • Clinic patients
Supplementary Information
COVID-19 positive and recovered patients are recruited from Mount Sinai Hospital patient population. Patients are approached to participate, then they are provided with the consent form and information on how to contact the research coordinator for this study. The COVID-19 infected patients participate in this study after they have recovered from the infection and are no longer infected (not hospitalized patients).

Sample Size

Number of Participants
10
Number of Participants with Biological Samples
10

Data Collection Events

# Name Description Start End
0 LSPIPSA-HCW - COVID-19 infected - ELISA capillary blood samples 2020 (September) Ongoing
LSPIPSA-HCW - COVID-19 negative and untested

Selection Criteria

Countries
  • Canada
Territory
Toronto
Health Status
  • COVID-19 untested or previously negative

Sources of Recruitment

Specific Population
  • Members of an association
Supplementary Information
Participants will be recruited by word of mouth from within the health care workers at the Mount Sinai Hospital.

Sample Size

Number of Participants
10
Number of Participants with Biological Samples
10

Data Collection Events

# Name Description Start End
0 LSPIPSA-HCW - COVID-19 negative and untested - ELISA capillary blood samples 2020 (September) Ongoing
LSPIPSA-HCW - Longitudinal

Selection Criteria

Countries
  • Canada
Territory
Ontario
Other Criteria
Exclusion: Present symptoms compatible with COVID-19 infections and for those with confirmed COVID-19 positive had a negative NP swab test for COVID-19 (recovered from COVID-19)

Sources of Recruitment

Specific Population
  • Members of an association
Supplementary Information
Information about this study was electronically distributed to the health care workers (HCWs) at the Mount Sinai Hospital, Sault Area Hospital and Health Sciences North (Sudbury). Volunteers will contact the research coordinator and will be eligible to participate in the study if they are able to provide the blood samples and if they are willing to complete the entire 18 months of the study.

Sample Size

Number of Participants
1,700
Number of Participants with Biological Samples
1,700

Individual Studies Included

Acronym Name Study design Participants Countries

Harmonization Projects Included

Acronym Name

Networks

Acronym Name Studies

Datasets

Name Type Data Collection Events Variables
Last Update: 2021-07-30 14:38